Published Oct 10, 2023

Ozempic

Michael Hobbes and Aubrey Gordon delve into the societal and healthcare implications of Ozempic, a weight loss drug, critiquing its impact on discourse and stigma around obesity, while scrutinizing its marketing strategies and effectiveness amid challenges like drug shortages.

Episode Highlights

Topics covered

Episode Highlights

Related Episodes

Dr. Oz
Answers 383 questions
The Obesity Epidemic
Answers 383 questions
Zombie Statistics Spectacular!
Answers 383 questions
Doctors Have a New Plan for Fat Kids
Answers 383 questions
Olestra
Answers 383 questions
“Glorifying Obesity” And Other Myths About Fat People
Answers 383 questions
The Body Mass Index
Answers 383 questions
Weight Watchers
Answers 383 questions
"Super Size Me"
Answers 383 questions
Fen Phen & Redux
Answers 383 questions
Oprah Winfrey & The “Wagon of Fat”
Answers 383 questions
Fat Camps
Answers 383 questions
"Soy Boys"
Answers 383 questions
Goop
Answers 383 questions
Mini-Sode: The Dr. Oz Campaign
Answers 383 questions

Dexa/Maintenance Phase

Ozempic

Topics covered

Popular Clips

Side Effects and Stigma

Challenging Weight Loss Stigma

The GLP One Agonist

Weight Loss Drugs, Fat Activism

Weight Loss Drugs Reality Check

Weight Loss Medication Shortage

Troubling Discourse

The Stakes of Fatness

Challenging Weight Stigma

Body Image Discourse

Weight Loss Drugs

The Weight Loss Drug Dilemma

Breaking Down Fatphobia

Episode Highlights

Societal Implications

Marketing and Discourse

Weight Loss Drugs

Related Episodes

Dr. Oz

The Obesity Epidemic

Zombie Statistics Spectacular!

Doctors Have a New Plan for Fat Kids

Olestra

“Glorifying Obesity” And Other Myths About Fat People

The Body Mass Index

Weight Watchers

"Super Size Me"

Fen Phen & Redux

Oprah Winfrey & The “Wagon of Fat”

Fat Camps

"Soy Boys"

Goop

Mini-Sode: The Dr. Oz Campaign

Ozempic

Topics covered

Popular Clips

Episode Highlights

Societal ImplicationsMichael Hobbes and Aubrey Gordon critically examine the implications of Ozempic, a weight loss drug, on healthcare stigma and accessibility. They explore how these drugs are reshaping conversations around obesity, often perpetuating existing biases and inequities.

Societal Implications

Marketing and DiscourseThe marketing strategies and media narratives surrounding Ozempic reveal a complex interplay of promotion and perception. Aubrey Gordon and Michael Hobbes critically examine how these elements shape public discourse on obesity and weight loss.

Marketing and Discourse

Weight Loss DrugsThe discussion shifts to the trials and real-world application of semaglutide, a drug hailed for its weight loss potential. Michael Hobbes and Aubrey Gordon explore its effectiveness, side effects, and the challenges posed by its shortage.

Weight Loss Drugs

Related Episodes